Kidney Cancer Doctors in Turkey — Page 2

Professor of oncosurgery and proctology

Professor Turkan Ozturk Topcu is a medical oncology specialist at Valued Med Hub Hospitals who trained at the world-renowned MD Anderson Cancer Center in the USA.

• Specialises in medical oncology for kidney and urological cancers
• Trained at Moffitt Cancer Center, a top American facility for cancer research
• Completed a clinical programme at Sunnybrook Odette Cancer Centre in Canada
• Uses systemic therapies to manage both early and advanced renal tumours
• Fellow of the Karadeniz Technical University Faculty of Medicine

Associate Professor Yusuf Acikgoz brings high-level expertise from The Ohio State University to his role leading medical oncology at Lokman Hekim University.

• Specialises in systemic therapies for kidney cancer including immunotherapy and targeted drug regimes
• Served as an investigator on major Phase III global clinical trials for new cancer treatments
• Completed specialised immuno-oncology training with the Central European Cooperative Oncology Group in Vienna
• Active member of the American Society of Clinical Oncology since 2022
• Recognised for clinical research involving human subjects protection and laboratory animal research standards

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Associate Professor Nail Paksoy is a European-certified medical oncologist specialising in advanced kidney cancer treatments and immunotherapy at Medipol Bahçelievler University Hospital.

• ESMO Board Certified in Medical Oncology – recognised for meeting high European standards in cancer care
• Expert in metastatic renal cell carcinoma (RCC) – handles complex cases with spread to the brain or other organs
• Focuses on immunotherapy protocols including Atezolizumab for improved outcomes in urological cancers
• Sub-investigator for international clinical trials with major pharmaceutical companies like Roche and Pfizer
• Extensively published in uro-oncology with specific research on drug resistance in kidney cancer

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Alemdar is a medical oncology specialist at the Medical Park Antalya Hospital Complex with deep roots in academic medicine.

• Trained at Akdeniz University across internal medicine and medical oncology subspecialties
• Managed complex oncology cases at Antalya Training and Research Hospital
• Focuses on systemic treatments for kidney cancer including immunotherapy and targeted drug protocols
• Experienced in multi-disciplinary care settings at major Turkish university hospitals

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Serkan Deveci is a senior urologist at Medical Park Göztepe Hospital, specialising in the surgical management of urological cancers and complex retroperitoneal procedures.

• Performs retroperitoneal lymph node dissection to remove affected lymph nodes in advanced cancer cases
• Expert in radical prostatectomy and managing functional outcomes after major urological surgery
• Published extensive research on surgical recovery and sexual health preservation with the American Urology Association
• Holds a Professor title from Acıbadem University, reflecting his status as a leading surgical educator

Associate Professor Turkan Ozturk Topcu is a medical oncologist at Biruni University Hospital with international training from the world-leading MD Anderson Cancer Centre.

• Completed specialist medical oncology residencies at major university research hospitals
• Holds active memberships in the American Society of Clinical Oncology (ASCO)
• Practises at Biruni University Hospital – a key centre for academic medical research
• Member of the European Society for Medical Oncology (ESMO)
• Uses targeted drug protocols to manage various stages of kidney cancer

Professor Elnur Sahibov is a radiation oncology specialist at the JCI-accredited Emsey Hospital, focusing on targeted cancer treatments.

• Trained at Marmara University Faculty of Medicine in radiation oncology
• Specialises in precise radiation therapy to target tumours while sparing healthy kidney tissue
• Experienced in treating both primary and advanced cases of kidney cancer
• Works within a multidisciplinary team to coordinate surgical and radiation care

The doctor is a seasoned General Surgeon at Anadolu Medical Center with 23 years of experience. Specializing in General Surgery, Surgical Infections, Breast Cancer, Thyroid/Parathyroid Surgery, and Advanced Minimally Invasive Surgery, the doctor also focuses on Pancreatic Cancer and Glucose Metabolism. Graduating from Hacettepe University School of Medicine in 1990, the doctor completed specialization training in General Surgery in 1996. Actively associated with numerous professional organizations, the doctor has authored 31 international and 22 national publications, contributing significantly to medical literature.

Professor Ahmet Cag Cal is a heavyweight in urological oncology, having refined his surgical expertise at world-leading institutions like the Mayo Clinic and Memorial Sloan-Kettering Cancer Center.

• Specialises in kidney cancer surgery with a focus on preserving organ function
• Developed surgical protocols as Professor of Medicine at Ege University
• Conducted research into molecular genetics at UCLA to improve patient outcomes
• Served as Vice Dean of the Izmir University of Economics Faculty of Medicine
• Member of the American Urological Association and European Association of Urology